LB Pharmaceuticals Inc Common Stock (LBRX)

About LBRX

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

lbpharma.us/

Fundamentals

Market cap

$1.38B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.72

Dividend yield

—

Beta

1.59

Avg. volume

—

LB Pharmaceuticals Inc Common Stock Competitors

Chosen by industry and closest market cap.

• LBRX

  LB Pharmaceuticals Inc Common Stock

  $47.8

  ▼ 0.20%
  Market cap $1.38BP/E —
  $13.36$50.16
• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.33BP/E —
  $10.95$23.02
• PAHC

  Phibro Animal Health Corporation Class A Common Stock

  $37.64

  ▲ 3.55%
  Market cap $1.44BP/E 14.51
  $28.25$60.08
• AVBP

  ArriVent BioPharma Inc. Common Stock

  $30.19

  ▼ 2.63%
  Market cap $1.44BP/E —
  $17$35.83
• AVLN

  Avalyn Pharma Inc. Common Stock

  $34.67

  ▼ 5.04%
  Market cap $1.45BP/E —
  $24.15$40.17
• XNCR

  Xencor Inc. Common Stock

  $26.06

  ▼ 9.76%
  Market cap $1.48BP/E —
  $7.83$30.61
• HROW

  Harrow Inc. Common Stock

  $37.23

  ▼ 3.40%
  Market cap $1.49BP/E —
  $28.54$54.85

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Maintains Buy on LB Pharmaceuticals, Raises Price Target to $60
  benzinga · 8/24/2026
• Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday
  Benzinga · 8/24/2026
• HC Wainwright & Co. Maintains Buy on LB Pharmaceuticals, Raises Price Target to $60
  Benzinga · 8/24/2026
• Are Biotech Stocks The 'Comeback Kid' Of 2026? I Say Yes
  SeekingAlpha · 8/16/2026
• BMO Capital Maintains Outperform on LB Pharmaceuticals, Raises Price Target to $54
  Benzinga · 8/12/2026
• LB Pharmaceuticals Q2 EPS $(1.71) Misses $(0.80) Estimate
  Benzinga · 8/11/2026
• HC Wainwright & Co. Reiterates Buy on LB Pharmaceuticals, Maintains $45 Price Target
  Benzinga · 8/3/2026

• Deep Track Biotechnology Master Fund, Ltd. · July 30, 2026 · Buy

  286.2K @ $34.94
• Luse Rebecca · June 3, 2026 · Grant

  10.0K
• Robert A. Lenz · June 3, 2026 · Grant

  12.5K
• Kane William P Jr · June 3, 2026 · Grant

  10.0K
• Rekha Hemrajani · June 3, 2026 · Grant

  10.0K
• Ran Nussbaum · June 3, 2026 · Grant

  10.0K
• Garland J. Scott · June 3, 2026 · Grant

  10.0K
• RUFFOLO ROBERT R · June 3, 2026 · Grant

  10.0K
• Robert A. Lenz · March 6, 2026 · Grant

  20.0K

Institutional Ownership

March 31, 2026

Total shares held

26.50M

Total value held

$652.03M

Institutional holders

73